Search research articles
Contact Us
Filters
Showing results (921-930 of 1,079) with videos related to
Page
of 108
Sort By:
Journal of Neurology
|
June 12, 2026
Impact of awareness of genetic status on cognitive, behavioral, and neuropsychiatric outcomes in genetic frontotemporal dementia
Liset de Boer, Babette Reichard, Jackie M Poos, et al.
Plos One
|
April 10, 2014
Actual and preferred place of death of home-dwelling patients in four European countries: making sense of quality indicators
Maaike L De Roo, Guido Miccinesi, Bregje D Onwuteaka-Philipsen, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Assessment of partially deoxygenated deoxynojirimycin derivatives as glucosylceramide synthase inhibitors
Richard J B H N van den Berg, Tom Wennekes, Amar Ghisaidoobe, et al.
The Open Virology Journal
|
January 19, 2012
Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008
Frederika Dijkstra, Marcel Jonges, Ruud van Beek, et al.
Intensive Care Medicine
|
January 4, 2023
Prognostic models for mortality risk in patients requiring ECMO
Lara C A Pladet, Jaimie M M Barten, Lisette M Vernooij, et al.
Plos One
|
January 7, 2014
Do intensive care data on respiratory infections reflect influenza epidemics?
Antonie Koetsier, Liselotte van Asten, Frederika Dijkstra, et al.
Organic & Biomolecular Chemistry
|
August 27, 2014
Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitors
Kah-Yee Li, Jianbing Jiang, Martin D Witte, et al.
BMJ Open
|
May 5, 2021
European List of Essential Medicines for Medical Education: a protocol for a modified Delphi study
Erik Donker, David Brinkman, Milan Richir, et al.
BMC Health Services Research
|
March 11, 2018
Cost-effectiveness in extracorporeal life support in critically ill adults in the Netherlands
Annemieke Oude Lansink-Hartgring, Dinis Dos Reis Miranda, Dirk W Donker, et al.
Molecular Genetics and Metabolism
|
April 22, 2008
Treatment of Fabry disease with different dosing regimens of agalsidase: effects on antibody formation and GL-3
Anouk C Vedder, Frank Breunig, Wilma E Donker-Koopman, et al.
Page
of 108
Search research articles
Search
Showing results (921-930 of 1,079) with videos related to
Sort By:
Page
of 108
Journal of Neurology
|
June 12, 2026
Impact of awareness of genetic status on cognitive, behavioral, and neuropsychiatric outcomes in genetic frontotemporal dementia
Liset de Boer, Babette Reichard, Jackie M Poos, et al.
Plos One
|
April 10, 2014
Actual and preferred place of death of home-dwelling patients in four European countries: making sense of quality indicators
Maaike L De Roo, Guido Miccinesi, Bregje D Onwuteaka-Philipsen, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Assessment of partially deoxygenated deoxynojirimycin derivatives as glucosylceramide synthase inhibitors
Richard J B H N van den Berg, Tom Wennekes, Amar Ghisaidoobe, et al.
The Open Virology Journal
|
January 19, 2012
Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008
Frederika Dijkstra, Marcel Jonges, Ruud van Beek, et al.
Intensive Care Medicine
|
January 4, 2023
Prognostic models for mortality risk in patients requiring ECMO
Lara C A Pladet, Jaimie M M Barten, Lisette M Vernooij, et al.
Plos One
|
January 7, 2014
Do intensive care data on respiratory infections reflect influenza epidemics?
Antonie Koetsier, Liselotte van Asten, Frederika Dijkstra, et al.
Organic & Biomolecular Chemistry
|
August 27, 2014
Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitors
Kah-Yee Li, Jianbing Jiang, Martin D Witte, et al.
BMJ Open
|
May 5, 2021
European List of Essential Medicines for Medical Education: a protocol for a modified Delphi study
Erik Donker, David Brinkman, Milan Richir, et al.
BMC Health Services Research
|
March 11, 2018
Cost-effectiveness in extracorporeal life support in critically ill adults in the Netherlands
Annemieke Oude Lansink-Hartgring, Dinis Dos Reis Miranda, Dirk W Donker, et al.
Molecular Genetics and Metabolism
|
April 22, 2008
Treatment of Fabry disease with different dosing regimens of agalsidase: effects on antibody formation and GL-3
Anouk C Vedder, Frank Breunig, Wilma E Donker-Koopman, et al.
Page
of 108